JP Morgan Chase’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,800
Closed -$253K 7691
2025
Q4
$253K Sell
7,800
-735,800
-99% -$31.5M ﹤0.01% 5406
2025
Q3
$42.2M Buy
743,600
+38,600
+5% +$1.98M ﹤0.01% 1516
2025
Q2
$35.1M Buy
+705,000
New +$31.9M ﹤0.01% 1559
2025
Q1
Sell
-34,700
Closed -$839K 7484
2024
Q4
$839K Buy
+34,700
New +$860K ﹤0.01% 4749
2024
Q3
Sell
-50,000
Closed -$1.01M 7521
2024
Q2
$1.01M Buy
+50,000
New +$832K ﹤0.01% 4275

Other funds holding HIMS

JP Morgan Chase's HIMS Position: Q1 2026 in Review

JP Morgan Chase reduced its Hims & Hers Health (HIMS) stake by 72% in Q1 2026, selling an estimated $321M and leaving 5,240,816 shares worth $98.4M. The position accounts for 0.01% of the portfolio, ranked #992.

JP Morgan Chase first reported a position in HIMS in Q3 2020 and has held it in 21 quarters since. The position peaked at $1.01B in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • JP Morgan Chase held 5,240,816 shares of Hims & Hers Health worth $98.4M as of Q1 2026.
  • JP Morgan Chase sold 13,597,454 Hims & Hers Health shares in Q1 2026, an estimated $321M.
  • Hims & Hers Health made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #992 holding.
  • JP Morgan Chase first reported a position in Hims & Hers Health in Q3 2020 and has held it in 21 quarters since.
  • JP Morgan Chase's Hims & Hers Health position peaked at $1.01B in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.